Ischemia Modified Albumin Protein (IMA)
IMA
宿主: 人
宿主: Human
Native
> 90 %
SDS, WB, Imm, PC
-
- 抗原 See all Ischemia Modified Albumin (IMA) products
- Ischemia Modified Albumin (IMA)
- 蛋白类型
- Native
- 宿主
- 人
-
资源
- Human
- 应用范围
- SDS-PAGE (SDS), Western Blotting (WB), Immunogen (Imm), Positive Control (PC)
- 纯度
- > 90 %
-
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 说明
-
Isoelectric Point:
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Reconstitute in sterile PBS, pH 7.2 - pH 7.4.
- 缓冲液
- 20 mM Tris, 150 mM NaCl, pH 8.0, containing 1 mM EDTA, 1 mM DTT, 0.01 % SKL, 5 % Trehalose and Proclin300.
- 储存液
- ProClin
- 注意事项
- Avoid repeated freeze/thaw cycles
- 储存条件
- 4 °C,-80 °C
- 储存方法
- Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
- 有效期
- 12 months
-
- 抗原
- Ischemia Modified Albumin (IMA)
- 别名
- Ischemia Modified Albumin (IMA 产品)
- 背景
- Ischemia Modified Albumin is also called Human serum albumin. Human serum albumin is the most abundant protein in human blood plasma. It is produced in the liver. Albumin constitutes about half of the blood serum protein. It is soluble and monomeric. Albumin is synthesized in the liver as preproalbumin, which has an N-terminal peptide that is removed before the nascent protein is released from the rough endoplasmic reticulum. It has a molecular mass of 67 kDa. Human albumin is often used to replace lost fluid and help restore blood volume in trauma, burns and surgery patients. A Cochrane systematic review[6] of 37 trials found no evidence that albumin, compared with cheaper alternatives such as saline, reduces the risk of dying.
- 分子量
- 68 kDa
-
You are here:
